![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.biospectrumasia.com/news/26/21886/koreas-qurient-inks-agreement-with-tb-alliance-for-new-anti-tuberculosis-agent.html
https://www.prnewswire.com/news-releases/qurient-co-ltd-and-tb-alliance-announce-exclusive-license-agreement-for-telacebec-q203-a-new-anti-tuberculosis-agent-301738149.html
https://www.bloomberg.com/press-releases/2022-09-14/qurient-announces-collaboration-agreement-with-msd-to-evaluate-selective-cdk7-inhibitor-q901-in-combination-with-keytruda
https://www.businesswire.com/news/home/20200526005163/en/Qurient-Announces-U.S.-FDA-Clearance-IND-Application